Background: Methamphetamine abuse and dependence is currently a considerable problem.
Objective: To explain the efficacy of buprenorphine in the quick management of methamphetamine related anxiety and depressive disorders and also methamphetamine withdrawal craving.
Results: 52 mg of buprenorphine is very valuable in the treatment of severe methamphetamine related anxiety and depression and also methamphetamine craving.
Discussion: This study lightens that high dose of buprenorphine is quite effective in the lowering of anxiety, depression, and chest pain and methamphetamine withdrawal symptoms. Hence, our finding is a substantial addition to the literature.
Conclusions: We resulted that a single high dose of buprenorphine could quickly subside methamphetamine induced anxiety, depression, psychogenic pain and withdrawal symptoms. It looks that buprenorphine may be a safe and valuable drug for the treatment of the majority of methamphetamine associated disorders.
Published on: Mar 8, 2016 Pages: 1-3
Columbia University, USA
Journal of Novel Physiotherapy and Physical Rehabilitation
Ohio State University, USA
Peertechz Journal of Bioinformatics and Biostatistics
National Center for Toxicological Research (NCTR)/FDA, USA
Global Journal of Anesthesiology
Peter Lloyd Nara
Private Compnay- Biological Mimetics, Inc., USA
Annals of Antivirals and Antiretrovirals
University of Genoa, Italy
Global Journal of Allergy